Role of the microenvironment in regulating early stages of thymic involution and central tolerance
Role of the microenvironment in regulating early stages of thymic involution and central tolerance
批准号:
10553994
负责人:
Lauren Ilyse Richie EHRLICH
金额:
$79.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-15 至 2028-02-29
关键词:
AdultAgeAgingAntigen-Presenting CellsAutoantigensAutoimmuneAutoimmune DiseasesAutoimmunityAvidityBiological AssayBone MarrowCell AgingCell CompartmentationCell physiologyCellsCellularityDataData SetDefectDevelopmentFrequenciesGene Expression ProfilingGenerationsGeneticGoalsHealthHematopoiesisHematopoieticHumanImageImmune responseImmunityImpairmentIncidenceLigandsLongevityLymphoidLymphopoiesisMaintenanceMalignant NeoplasmsMediatorMolecularMorbidity - disease rateMusOutputPeripheralPredispositionProcessProductionRegulatory T-LymphocyteRejuvenationRoleSex BiasSignal TransductionSliceStromal CellsStructureT cell responseT-Cell DevelopmentT-LymphocyteTestingTherapeuticThymus GlandTumor AntigensVaccinescentral tolerancefetalfunctional restorationimaging approachimmune functionimprovedmiddle agemouse modelnotch proteinpathogenpreventprogenitorprogramsresponsestem cellsthymocytetwo-photon
中文摘要
ABSTRACT-Project 2
英文摘要
ABSTRACT-Project 2
During the process of age-associated thymus involution, T cell output progressively declines, contributing to
a reduction in naive T cells in older humans and mice. The resultant decline in new T-cell responses to
pathogens, vaccines, and cancers, leads to compromised immunity and increased morbidity with age. Thus, it
is important to elucidate mechanisms underlying reduced thymic function in order to improve human health
throughout the lifespan. In the past Project period, we found that early T-cell progenitors (ETPs), which give rise
to all downstream thymocyte subsets, decline in numbers surprisingly early, by 3 months (mo) of age. ETP
cellularity remains proportional to downstream thymocyte subsets at all ages, indicating the early decline in ETPs
sets the stage for diminished thymopoiesis during thymic involution. Because ETPs are the direct progeny of
circulating thymic seeding progenitors (TSPs), we anticipated a decline in the number of functional TSP niches
by 3mo of age. However, our data reveal that the available TSP niches do not decline through at least 12mo of
age, raising the question of what mechanisms underlie the early reduction in ETPs. Our preliminary data suggest
that changes in the BM and thymus microenvironments contribute to the early loss in ETPs. Although the
underlying mechanisms are not yet resolved, preliminary data suggest diminished NOTCH signaling in BM
lymphoid progenitors and thymic ETPs contribute. Thus, we will use genetic mouse models and advanced
imaging approaches to test if reduced expression of Notch ligands, and/or changes in other signals identified
through additional single-cell transcriptional profiling (Core B), are responsible for the early decline in lymphoid
progenitors in the BM (Aim 1) and ETPs in the thymus (Aim 2), and whether comparable mechanisms impact
the aging human thymus (Core C). We will also test if restoring NOTCH signaling rescues cellularity of BM
lymphoid progenitors, ETPs and thymocytes, and downstream T cell function in aging mice (P3 and Core D).
Changes in the cellular composition and organization of the thymic microenvironment during involution
may impact not only the quantity, but also the quality of developing T cells with age. During the previous Project
period, we found that by middle age, the thymus becomes impaired in its ability to support central tolerance
through both negative selection and regulatory T cell generation, particularly in response to low avidity self-
antigens. New onset autoimmunity also peaks at middle age in humans, suggesting a role for impaired central
tolerance. Thus, we will analyze current single-cell transcriptional profiling datasets from P2 and P1 (Core B)
and perform live 2-photon imaging and thymic slice assays to identify age-associated changes in the mouse and
human (Core C) thymic microenvironments that impair central tolerance and increase autoimmune susceptibility
by middle-age (Aim 3). P2 is tightly integrated with P1, P3, and the Cores. P2 results will be integral to achieving
the overall Program goals of elucidating mechanisms underlying age-associated defects in T-cell production and
selection and devising therapeutic strategies to restore functional T cell output and immunity with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
-
批准号:10200461
-
项目类别:
-
资助金额:$96.32万
-
财政年份:2020
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
-
批准号:10022939
-
项目类别:
-
资助金额:$51.96万
-
财政年份:2020
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
-
批准号:10251300
-
项目类别:
-
资助金额:$50.94万
-
财政年份:2020
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
-
批准号:10470932
-
项目类别:
-
资助金额:$50.88万
-
财政年份:2020
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
-
批准号:10689304
-
项目类别:
-
资助金额:$74.45万
-
财政年份:2020
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
-
批准号:10411920
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
-
批准号:10265640
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
-
批准号:8820882
-
项目类别:
-
资助金额:$51.57万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
-
批准号:9011993
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
-
批准号:9230336
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
-
批准号:10186450
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
-
批准号:8629092
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2014
-
负责人:Lauren Ilyse Richie EHRLICH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: